Memorial Şişli Hospital
Memorial Şişli Hospital
Turquia, Istambul
Betul Tavil
29 tahun pengalaman
akreditasi :
Klinik telah bersertifikat :
| Turquia | Austria | Spanyol | |
| Transplantasi sumsum tulang autologus | dari $31,000 | dari $50,000 | dari $40,000 |
| Transplantasi sumsum tulang alogenik dari donor tidak sedarah | dari $71,500 | dari $180,000 | dari $150,000 |
| Transplantasi sumsum tulang allogenik dari donor terkait | dari $53,500 | dari $150,000 | dari $13,728 |
| Transplantasi sumsum tulang | dari $36,000 | dari $140,000 | dari $71,782 |
| Tomoterapi | dari $12,000 | dari $30,000 | dari $35,000 |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Onkologi Pediatrik. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Onkologi Pediatrik dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Onkologi Pediatrik Anda.
Spesialis dalam kanker mata anak dengan pelatihan lanjutan di Wills Eye Institute – pemimpin global dalam onkologi okular.
Profesor Tavil telah melakukan 100+ transplantasi sel punca hematopoietik dan merawat 500+ anak dengan leukemia di Rumah Sakit Memorial Şişli.
Dokter memiliki pengalaman luas dalam bidang oftalmologi, mengkhususkan diri dalam perawatan dan operasi untuk strabismus, estetika mata, ambliopia, katarak, dan penyakit retina. Selain itu, dokter mahir dalam kesehatan mata anak dan melakukan pemeriksaan mata umum yang komprehensif.<\/p>
Lulus dari Fakultas Kedokteran Istanbul, dokter menyelesaikan spesialisasi di Rumah Sakit Pelatihan dan Penelitian Mata Beyoğlu. Dokter adalah anggota Asosiasi Medis Turki, Asosiasi Oftalmologi Turki, dan Masyarakat Eropa untuk Ahli Bedah Katarak dan Refraktif.<\/p>
Lebih dari 20 tahun berdedikasi pada onkologi pediatrik – Prof. Ahmet Demir berspesialisasi dalam leukemia akut dan limfoma Hodgkin di Rumah Sakit Memorial Ankara.
Turkey is a safe, highly reliable destination for pediatric oncology. Major centers in Istanbul and Ankara meet international safety protocols. Facilities like Memorial Şişli Hospital and Anadolu Medical Center hold JCI accreditation. They report success rates exceeding 80% for common childhood cancers like leukemia.
Bookimed Expert Insight: Data shows a strong link between high patient volume and specialized success. Medipol Mega University Hospital treats 1,000,000 patients annually and was named the best clinic for pediatric cancer in 2019. Choosing these high-capacity centers often ensures access to established pediatric-specific bone marrow transplant units that smaller clinics may lack.
Patient Consensus: Patients note that Turkish centers provide excellent routine care and comfortable environments for children. Some families advise confirming long-term follow-up plans with local doctors at home before starting intensive protocols abroad.
Childhood cancer survival rates in Turkey reach 71% overall, with specialized centers reporting success over 80–90% for common cases. Hodgkin lymphoma success rates hit 98%, while leukemia survival exceeds 85%. Leading hospitals like Anadolu Medical Center and Medipol Mega University Hospital follow international treatment protocols.
Bookimed Expert Insight: Medipol Mega University Hospital serves roughly 1,000,000 patients annually and was ranked the best for pediatric cancer care by Bookimed. This massive patient volume allows their specialists to manage rare cases that smaller clinics see only once a decade. High-volume centers often provide more stable outcomes for complex solid tumors like neuroblastoma.
Patient Consensus: Parents find that top Istanbul hospitals offer the same medical protocols as the US or Europe. Many feel relieved that their children receive advanced care while spending significantly less than they would in Western clinics.
Families should plan for an initial stay of 3 to 4 weeks in Turkey for pediatric oncology. This timeframe covers essential diagnostics and the first phase of treatment. Complex procedures like bone marrow transplants or intensive chemotherapy often require extended stays of several months.
Bookimed Expert Insight: Data shows that top-rated centers like Medipol Mega University Hospital and Anadolu Medical Center serve massive patient volumes. These institutions often function as all-in-one hubs where diagnostics and treatment happen under one roof. Choosing such a multi-specialty complex can pull your total stay down by several days. You avoid traveling between separate labs and clinics for scans or blood work.
Patient Consensus: Parents recommend staying within 15 minutes of the hospital to reduce daily stress. They suggest adding 3 buffer days to your trip to handle any unexpected medical consultations.
Turkish hospitals like Anadolu Medical Center and Memorial Şişli Hospital are globally recognized for pediatric oncology excellence. These JCI-accredited centers offer advanced treatments including CAR-T therapy, bone marrow transplantation, and CyberKnife. Specialized professors often have training from top U.S. institutions like Cincinnati Children's and Johns Hopkins.
Bookimed Expert Insight: Data shows a strong trend of academic integration in Istanbul. For example, Dr. Ceyhun Bozkurt at Medical Park and Dr. Betül Tavil at Memorial both bring expertise from elite U.S. centers like Cincinnati Children's. This high concentration of Western-trained specialists in single multi-specialty hubs allows for rapid, cross-departmental care that is often faster than in European centers.
Patient Consensus: Families note that staying for 6–12 months is common. They recommend using the initial online consultations to check how well the doctor communicates before traveling.
Turkish pediatric oncology centers provide specialized support including 24/7 personal coordinators, professional interpreters, and hospital-affiliated accommodation. Facilities like Anadolu Medical Center and Memorial Şişli Hospital offer JCI-accredited care with dedicated international departments. These teams manage airport transfers, visa extensions, and localized logistics for families during intensive treatments.
Bookimed Expert Insight: High-volume centers like Medipol Mega Hospital, which serves 1,000,000+ patients annually, often have the most robust infrastructure for long-term stays. Our data shows that clinics with JCI and ESMO accreditations typically provide more comprehensive family-centered care. Choosing a facility with a high review count, such as Anadolu Medical Center with 400+ reviews, usually ensures more experienced international patient coordination.
Patient Consensus: Parents note the importance of requesting a coordinator fluent in your language from the start. They also recommend using translation apps for daily needs outside the hospital setting.
Leading Turkish hospitals for paediatric oncology include Medipol Mega University Hospital, Anadolu Medical Center, and Memorial Şişli Hospital. These JCI-accredited centres specialise in complex cases like leukaemia and neuroblastoma. They provide treatments like bone marrow transplants and robotic surgery, guided by multidisciplinary tumour boards.
Bookimed Expert Insight: Medipol Mega University Hospital stands out because it performs the highest number of transplants in Turkey. This volume is critical for families. High-volume centres often have more experience managing post-transplant care. The hospital also offers CAR T-cell therapy. This is a vital option for children with refractory leukaemia, provided by Professor Ceyhun Bozkurt.
Patient Consensus: Patients in Turkey report that diagnostic staging and scans happen very quickly. This speed provides huge relief during an uncertain time. One patient noted that specialists explain risk categories in simple terms. This helps families understand all possible treatment options in detail before starting therapy.
Turkey is safe and highly capable for paediatric oncology. Leading hospitals in Istanbul and Ankara offer specialised bone marrow units. They also provide infection-controlled isolation rooms and modern radiotherapy. Facilities like Anadolu Medical Center maintain international standards. Their JCI accreditation and affiliation with Johns Hopkins Medicine support this.
Bookimed Expert Insight: Turkish paediatric units often employ multidisciplinary tumour boards. In these boards, surgeons, oncologists, and geneticists review every case locally. This collective approach helps families avoid fragmented care. At Memorial Ataşehir Hospital, this integrated model supports complex organ transplants for children. These include children as young as newborns.
Patient Consensus: Families in Turkey often praise the warm, child-friendly atmosphere. They also appreciate the ease of having 15+ languages spoken in clinics. Parents note that airport transfers and personal coordinators are included. This makes navigating treatment far less stressful.
Turkey offers advanced paediatric oncology through JCI-accredited hospitals that combine multidisciplinary teams and modern technology. High success rates for childhood cancers, such as 90% in specific transplants, attract families from 167 countries. Clinics provide immediate access to intensive treatment without the waiting lists common in several western countries.
Bookimed Expert Insight: Turkish oncology hubs often house chemotherapy, radiotherapy, and surgical units in one building. At Memorial Göztepe Hospital, up to 40 children can receive chemotherapy simultaneously while multidisciplinary tumour boards review their progress. This integrated setup lets specialists adjust treatment daily based on rapid lab results. That speed is vital for fast-growing childhood tumours.
Patient Consensus: Parents find relief in how quickly Turkey-based clinics finish diagnostic staging and scans after a diagnosis. Families note that specialists explain risk categories in simple terms. They also provide constant support throughout the intensive treatment process.
Australian parents can easily arrange a second opinion in Turkey before travelling for paediatric oncology. Leading JCI-accredited hospitals provide remote consultations where specialised oncologists review medical reports and pathology. These sessions confirm diagnoses or adjust treatment plans for complex cases like neuroblastoma or leukaemia.
Bookimed Expert Insight: While many think a second opinion is just a video call, the real value lies in multidisciplinary boards. At centres like Memorial Göztepe, cases are reviewed by teams across 39 departments, including on-site genetics labs. This means the treatment plan accounts for rare markers before any travel is booked, potentially saving weeks of diagnostic time once in Istanbul.
Patient Consensus: Parents find that Turkish specialists explain risk categories in simple terms and arrange necessary staging scans very quickly. They note that acting immediately on a second opinion often provides the relief needed. This helps them feel they are in safe hands during a frightening time.
Patients receive a comprehensive medical packet and a structured aftercare plan. This ensures continuity with local specialists. Turkish centres provide pathology reports, imaging studies, and detailed treatment records. Ongoing support often includes remote reviews by the Turkish medical team. They monitor the recovery process.
Bookimed Expert Insight: Turkish oncology centres often use multidisciplinary tumour boards to plan the return home. At Memorial Göztepe Hospital, specialists across departments review each case together. This ensures the aftercare plan covers surgical, radiological, and nutritional needs. The plan is compiled into a single, coordinated document before the patient departs.
Patient Consensus: Families in Turkey find relief when doctors explain risk categories simply and expedite staging scans. Patients appreciate that specialists are always available to resolve issues quickly during the transition home.
Treatment stays in Turkey for paediatric oncology range from 2 to 4 weeks for diagnostics and surgery. Intensive therapies like bone marrow transplants often require 3 to 4 months. Turkish JCI-accredited centres customise timelines. These depend on the specific cancer type and the child's response to therapy.
Bookimed Expert Insight: Data suggests multi-specialty centres in Istanbul often provide initial staging results faster than generic hospitals. Memorial Şişli is one such centre. These facilities use on-site 3 Tesla MRI and digital PET/CT systems. This helps cut diagnostic wait times. For Australian families, this speed is vital. It allows treatment to start days earlier, which can improve long-term outcomes.
Patient Consensus: Families note that Turkish clinics conduct staging and scans very quickly. This provides immediate relief after a diagnosis. Parents often mention that specialists explain risk categories in simple terms. They also keep coordinators available for support throughout the stay.
Starting paediatric oncology treatment in Turkey requires a child's comprehensive medical history, original pathology slides, and DICOM imaging files. JCI-accredited centres like Memorial Şişli Hospital and Anadolu Medical Center use these to verify diagnoses before starting intensive therapies such as chemotherapy or bone marrow transplantation.
Bookimed Expert Insight: Turkish clinics often accept existing diagnostic reports to avoid redundant tests. Hospitals like Medipol Mega University Hospital, which patients recently ranked best for paediatric cancer care, use on-site molecular labs to verify high-risk neuroblastoma or leukaemia markers within days of arrival. This speed is critical for starting time-sensitive protocols.
Patient Consensus: Parents in Turkey found it a huge relief that staging tests and scans happened very quickly. Families note that doctors explain risk categories in simple terms and include children in diagnosis discussions when appropriate.